For the
purposes of IRB policy, research misconduct means knowing and willful
non-compliance with requirements of the conduct of research involving human
subjects. Examples of research misconduct might include any of the following:
- failing to
seek IRB approval before beginning research with human subjects, whether
knowingly or inadvertently
- failing to
seek renewal of IRB approval following the lapse of such approval
- failing to
report adverse events with human subjects
- modifying a
research protocol without consulting IRB
- failing to
adequately report risks to human subjects
- failing to
secure and properly document informed consent
The University and the IRB recognize that honest errors are an
inevitable part of the research process. To distinguish instances of knowing
and willful research misconduct from “honest” errors, simple carelessness, and
minor infractions, the IRB will conduct a for-cause audit, according to the
following procedures.
For-cause
Audit: Under 45 CFR 46.113 requirements, this review is
performed when concerns regarding compliance, protocol adherence, or subject
safety are brought to the attention of the IRB or the IRB Monitor. This audit may
take place on-site or on the Seattle University campus, at the discretion of
the IRB, and may include review of:
1. Protocol file/regulatory documentation
2. IRB Documentation
3. Consent/Assent Forms
4. Individual Participant Records. A random sample to determine if :
a)
The participants met the inclusion/exclusion
criteria for the study.
b)
Study related procedures are performed according to
the protocol.
c)
Study related procedures are scheduled and
performed per the study time line.
d)
Data is recorded and stored securely as described
in the Consent Form.
Documents that may be selected for
review include, but are not limited to:
1.
Regulatory submissions and associated IRB
correspondence
2.
Changes in the protocol and associated IRB
correspondence
3.
Review of any lapses in IRB approvals
4.
Review of eligibility criteria
5.
Review of all informed consents
6.
Review of subject accrual and recruitment practices
7.
Review of data collection tools and procedures
8.
Review of adverse event reporting (including
timeliness of reports to the IRB, Sponsor and other regulatory agency.
9.
Review of protocol deviations (including timeliness of
reports to the IRB, Sponsor and other regulatory bodies)
10.
Review of continuing review reports
Audit Reports will be conducted by a
member of the IRB staff and at least one IRB board member. In the case of a for
cause audit, the IRB may request a 100% audit of study participant’s records
and/or collected data. The Report will be presented to the entire Board at the
next scheduled IRB Meeting. Subsequently, notification of observations of noncompliance will be sent
to the PI with a detailed explanation of the basis for the findings.
Actions will
not be taken by the IRB against any investigator or project without providing
the investigator an opportunity to provide information in writing that might
mitigate or refute an adverse finding.